- Macula
Anti-VEGF Intravitreal Injections
- Treatment
- Macula
Anti-VEGF Intravitreal Injections
An injection of anti-vascular endothelial growth factor (anti-VEGF) into the posterior chamber or vitreous cavity of the eye aims to reduce macular oedema, or abnormal blood vessel growth inside the eye.
What is Anti-VEGF Intravitreal Injections?
Anti-VEGF medicines stop the abnormal blood vessels leaking, growing and then bleeding under the retina. Vascular endothelial growth factor (VEGF) is a protein that promotes the growth of new blood vessels, but can also make the blood vessels more leaky. Anti-VEGF medications stop the growth of these new blood vessels. This prevents damage to the retinal light receptors and loss of central vision. These medicines are effective in preventing further central vision loss in up to 90% of treated eyes.
How is it performed?
- 1.The treatment is given in a sterile, comfortable environment
- 2.Topical anaesthetic is applied to the eye rendering the treatment pain-free
- 3.The anti-VEGF drug is injected through the white of the eye (sclera) into the vitreous or clear gel inside the posterior chamber or back of the eye.